SDP-4 Ophthalmic Solution (1.0%)
Sponsors
Silk Technologies, Ltd.
Conditions
Dry Eye
Phase 2
Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)
CompletedNCT03889886
Start: 2019-04-16End: 2019-10-11Updated: 2022-09-02
Study to Evaluate the Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) (SDP-4-CS202)
CompletedNCT04535947
Start: 2020-08-14End: 2021-02-10Updated: 2022-09-01